Other Nations Get OK To Produce Merck’s Covid Treatment Pill
Merck agreed to license its covid treatment molnupiravir for production by third-party drugmakers so that it can be accessed more easily in 105 low- and middle-income countries. Separately, Novavax has applied for U.K. authorization of its covid vaccine, the first protein-based shot in Europe.